Paving way for drug development at a fast pace
pipeline in numbers
pipeline statistics
pipeline
developement progress
Ongoing
Halted
PIPELINE/ONcology
Aiming to improve survival rates for the most lethal tumor forms, we primarily strive to develop novel and universal cancer therapies.
lead reasearch
ENA/VASP: Key-promoter of Cell Tumors
Ena/VASP is a highly sought after, yet so far undraggable target, they are family of proteins that regulate actin dynamics and physiological processes such as morphogenesis, endothelial barrier function, and cancer cell invasion and metastasis.
Cancer Types
lead reasearch
Role of ENA/VASP in
tumor growth
Tumors result from the unregulated accumulation of cancer cells. This abnormality is highly dependent on neoangiogenesis: the promotion of new blood vessels into the tumor tissue. Within this mechanism, Ena/VASP acts as a fundamental driver.
pipeline/discovery
While we focus on oncology in-house, we aim to fully utilize our platform’s potential and build a diversified portfolio of assets with strong partners on our side.
Neurodegenerative disease
Stimulants
Blood Drugs
Infectious Diseases
Cardiovascular Diseases
Further Diseases
Get in touch
